Journal Article

Impairments of GABAergic transmission in hippocampus mediate increased susceptibility of epilepsy in the early stage of Alzheimer’s disease

Xu, Bingsong, Shu, Shu, Liu, Xuan, Tan, Yi, Xu, Yun, Xu, Siyi, Bai, Feng, Hu, Mengsha, Sun, Min, Mao, Rui, Ye, Lei, Shao, Wenxuan

2024

Overview

Background Patients with Alzheimer’s disease (AD) are often co-morbid with unprovoked seizures, making clinical diagnosis and management difficult. Although it has an important role in both AD and epilepsy, abnormal γ-aminobutyric acid (GABA)ergic transmission is recognized only as a compensative change for glutamatergic damage. Neuregulin 1 (NRG1)-ErbB4 signaling can promote GABA release and suppress epileptogenesis, but its effects on cognition in AD are still controversial. Methods Four-month-old APPswe/PS1dE9 mice (APP mice) were used as animal models in the early stage of AD in this study. Acute/chronic chemical-kindling epilepsy models were established with pentylenetetrazol. Electroencephalogram and Racine scores were performed to assess seizures. Behavioral tests were used to assess cognition and emotion. Electrophysiology, western blot and immunofluorescence were performed to detect the alterations in synapses, GABAergic system components and NRG1-ErbB4 signaling. Furthermore, NRG1 was administrated intracerebroventricularly into APP mice and then its antiepileptic and cognitive effects were evaluated. Results APP mice had increased susceptibility to epilepsy and resulting hippocampal synaptic damage and cognitive impairment. Electrophysiological analysis revealed decreased GABAergic transmission in the hippocampus. This abnormal GABAergic transmission involved a reduction in the number of parvalbumin interneurons (PV + Ins) and decreased levels of GABA synthesis and transport. We also found impaired NRG1-ErbB4 signaling which mediated by PV + Ins loss. And NRG1 administration could effectively reduce seizures and improve cognition in four-month-old APP mice. Conclusion Our results indicated that abnormal GABAergic transmission mediated hippocampal hyperexcitability, further excitation/inhibition imbalance, and promoted epileptogenesis in the early stage of AD. Appropriate NRG1 administration could down-regulate seizure susceptibility and rescue cognitive function. Our study provided a potential direction for intervening in the co-morbidity of AD and epilepsy.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Alzheimer Disease - complications / Alzheimer's disease / Animal models / Animals / Behavior / Biomedical and Life Sciences / Brain research / Cell Biology / Cognition / Cognitive ability / Complications and side effects / Convulsions & seizures / Cytokines and Growth Factors / Development and progression / Drug dosages / EEG / Electrophysiology / Epilepsy / ErbB-2 protein / GABA / GABAergic transmission / gamma-Aminobutyric Acid / Glutamatergic transmission / Health aspects / Hippocampus / Hippocampus (Brain) / Hippocampus - metabolism / Homeostasis / Humans / Immunofluorescence / Infant / Interneurons / Kinases / Kindling / Life Sciences / Memory / Mice / Morbidity / Neural transmission / Neuregulin 1 / Neuregulin-1 - metabolism / Neurodegenerative diseases / NRG1 / Parvalbumin / Parvalbumin interneurons / Protein-Ligand Interactions / Receptor, ErbB-4 - metabolism / Receptors / Risk factors / Seizures / Synapses / Transgenic animals / γ-Aminobutyric acid